tetano
Editor, Senior Moderator
Pathog Dis
. 2020 Jul 7;ftaa033.
doi: 10.1093/femspd/ftaa033. Online ahead of print.
SARS, MERS, COVID-19: Clinical Manifestations and Organ-System Complications: A Mini Review
Jad Gerges Harb[SUP] 1 [/SUP], Hussein A Noureldine[SUP] 1 [/SUP], Georges Chedid[SUP] 1 [/SUP], Mariam Nour Eldine[SUP] 1 [/SUP], Dany Abou Abdallah[SUP] 2 [/SUP], Nancy Falco Chedid[SUP] 1 [/SUP], Wared Nour-Eldine[SUP] 1 [/SUP]
Affiliations
Abstract
Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and Coronavirus Disease 2019 (COVID-19) are caused by three distinct coronaviruses belonging to the same genus. COVID-19 and its two predecessors share many important features in their clinical presentations, and in their propensity for progression to severe disease which is marked by high rates of morbidity and mortality. However, comparison of the three viral illnesses also reveals a number of specific differences in clinical manifestations and complications, which suggest variability in the disease process. This narrative review delineates the pulmonary, cardiac, renal, gastrointestinal, hepatic, neurological, and hematologic complications associated with these three respiratory coronaviruses. It further describes the mechanisms of immune hyperactivation-particularly cytokine release syndrome-implicated in the multi-organ system injury seen in severe cases of MERS, SARS, and COVID-19.
Keywords: Acute Hepatic Injury; Acute Kidney Injury; Acute Neurologic Syndrome; Acute respiratory distress syndrome; Central neurogenic respiratory failure; Coronavirus disease 2019; Cytokine Release Syndrome; Heart Failure; Middle east respiratory syndrome coronavirus; Pneumonia; Severe acute respiratory syndrome coronavirus 1; Severe acute respiratory syndrome coronavirus 2.
. 2020 Jul 7;ftaa033.
doi: 10.1093/femspd/ftaa033. Online ahead of print.
SARS, MERS, COVID-19: Clinical Manifestations and Organ-System Complications: A Mini Review
Jad Gerges Harb[SUP] 1 [/SUP], Hussein A Noureldine[SUP] 1 [/SUP], Georges Chedid[SUP] 1 [/SUP], Mariam Nour Eldine[SUP] 1 [/SUP], Dany Abou Abdallah[SUP] 2 [/SUP], Nancy Falco Chedid[SUP] 1 [/SUP], Wared Nour-Eldine[SUP] 1 [/SUP]
Affiliations
- PMID: 32633327
- DOI: 10.1093/femspd/ftaa033
Abstract
Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and Coronavirus Disease 2019 (COVID-19) are caused by three distinct coronaviruses belonging to the same genus. COVID-19 and its two predecessors share many important features in their clinical presentations, and in their propensity for progression to severe disease which is marked by high rates of morbidity and mortality. However, comparison of the three viral illnesses also reveals a number of specific differences in clinical manifestations and complications, which suggest variability in the disease process. This narrative review delineates the pulmonary, cardiac, renal, gastrointestinal, hepatic, neurological, and hematologic complications associated with these three respiratory coronaviruses. It further describes the mechanisms of immune hyperactivation-particularly cytokine release syndrome-implicated in the multi-organ system injury seen in severe cases of MERS, SARS, and COVID-19.
Keywords: Acute Hepatic Injury; Acute Kidney Injury; Acute Neurologic Syndrome; Acute respiratory distress syndrome; Central neurogenic respiratory failure; Coronavirus disease 2019; Cytokine Release Syndrome; Heart Failure; Middle east respiratory syndrome coronavirus; Pneumonia; Severe acute respiratory syndrome coronavirus 1; Severe acute respiratory syndrome coronavirus 2.